Beta blockers and/or ACE inhibitors as cardioprotective strategy for patients affected by nonmetastatic breast cancer who are receiving an anthracycline-based chemotherapy (SAFE-NCT02236806): final results of a randomized trial

被引：1
|
作者：
Meattini, Icro
Becherini, Carlotta
Visani, Luca
Saieva, Calogero
Salvestrini, Viola
Martella, Francesca
Bacci, Carlotta
Molinara, Elena
Airoldi, Mario
Del Bene, Maria Riccarda
Amoroso, Domenico
Coltelli, Luigi
Desideri, Isacco
Scotti, Vieri
Bernini, Marco
Orzalesi, Lorenzo
Nori, Jacopo
Bianchi, Simonetta
Barletta, Giuseppe
Livi, Lorenzo
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-PD8-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD8-03
引用
收藏
页数：3
相关论文
共 12 条
  • [1] Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy A Randomized Clinical Trial
    Livi, Lorenzo
    Barletta, Giuseppe
    Martella, Francesca
    Saieva, Calogero
    Desideri, Isacco
    Bacci, Carlotta
    Del Bene, Maria Riccarda
    Airoldi, Mario
    Amoroso, Domenico
    Coltelli, Luigi
    Scotti, Vieri
    Becherini, Carlotta
    Visani, Luca
    Salvestrini, Viola
    Mariotti, Matteo
    Pedani, Fulvia
    Bernini, Marco
    Sanchez, Luis
    Orzalesi, Lorenzo
    Nori, Jacopo
    Bianchi, Simonetta
    Olivotto, Iacopo
    Meattini, Icro
    JAMA ONCOLOGY, 2021, 7 (10) : 1544 - 1549
  • [2] Pharmacological cardioprotective strategy for non-metastatic patients affected by breast cancer receiving an anthracycline-based chemotherapy: Final results of the phase 3 SAFE trial
    Livi, Lorenzo
    Barletta, Giuseppe
    Martella, Francesca
    Saieva, Calogero
    Becherini, Carlotta
    Bacci, Carlotta
    Del Bene, Maria Riccarda
    Airoldi, Mario
    Amoroso, Domenico
    Coltelli, Luigi
    Pilato, Giuseppe
    Visani, Luca
    Salvestrini, Viola
    Pedani, Fulvia
    Bernini, Marco
    Orzalesi, Lorenzo
    Nori, Jacopo
    Bianchi, Simonetta
    Olivotto, Iacopo
    Meattini, Icro
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Cardioprotective effect of Platycodon grandiflorum in patients with early breast cancer receiving anthracycline-based chemotherapy: study protocol for a randomized controlled trial
    Wei Hao
    Sheng Liu
    Yuenong Qin
    Chenping Sun
    Liying Chen
    Chunyu Wu
    Yijia Bao
    Trials, 18
  • [4] Cardioprotective effect of Platycodon grandiflorum in patients with early breast cancer receiving anthracycline-based chemotherapy: study protocol for a randomized controlled trial
    Hao, Wei
    Liu, Sheng
    Qin, Yuenong
    Sun, Chenping
    Chen, Liying
    Wu, Chunyu
    Bao, Yijia
    TRIALS, 2017, 18
  • [5] Cardioprotective strategy for non-metastatic breast cancer patients receiving an anthracycline-based chemotherapy: subgroup analysis focused on impact of postoperative breast radiation therapy of the preplanned interim analysis of the phase 3 SAFE trial (NCT2236806)
    Meattini, Icro
    Barletta, Giuseppe
    Becherini, Carlotta
    Visani, Luca
    Martella, Francesca
    Airoldi, Mario
    Amoroso, Domenico
    Coltelli, Luigi
    Bellini, Chiara
    Stocchi, Giulia
    Lorenzetti, Victoria
    Orsatti, Carolina
    Angelini, Lucia
    Livi, Lorenzo
    CANCER RESEARCH, 2022, 82 (04)
  • [6] Cardioprotective effect of crocin in patients with breast cancer receiving anthracycline-based chemotherapy: A randomized, double-blind, placebo-controlled study
    Li, Xinye
    Su, Xin
    Liang, Wanping
    Wang, Li
    Yuan, Chao
    Xu, Juping
    Zhang, Yijun
    Liu, Yan
    Ma, Ning
    Yang, Fan
    Yang, Yiyuan
    Tao, Liyuan
    Sun, Shipeng
    Shang, Hongcai
    Xing, Yanwei
    PHARMACOLOGICAL RESEARCH, 2025, 213
  • [7] Randomized, placebo-controlled trial of saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy
    Peterson, Douglas E.
    Jones, James B.
    Petit, Robert G., II
    CANCER, 2007, 109 (02) : 322 - 331
  • [8] Interim analysis of the SAFE trial (NCT2236806): A randomized phase 3 study evaluating a cardiovascular disease prevention strategy using beta-blockers and/or ACE inhibitors in non-metastatic breast cancer patients treated with anthracyclines
    Livi, Lorenzo
    Meattini, Icro
    Martella, Francesca
    Saieva, Calogero
    Becherini, Carlotta
    Terziani, Francesca
    Desideri, Isacco
    Scotti, Vieri
    Bacci, Carlotta
    Airoldi, Mario
    Allegrini, Giacomo
    Amoroso, Domenico
    Fioretto, Luisa
    Barletta, Giuseppe
    CANCER RESEARCH, 2020, 80 (04)
  • [9] Cardiac toxicity prevention in non-metastatic breast cancer patients treated with anthracycline-based chemotherapy: A randomized, placebo controlled, phase III trial-SAFE trial.
    Meattini, Icro
    Tarquini, Roberto
    Saieva, Calogero
    Valoriani, Alice
    Bonomo, Pierluigi
    Desideri, Isacco
    Loi, Mauro
    Scotti, Vieri
    De Luca, Carla
    Magrini, Cardillo Stefano M.
    Gensini, Gianfranco
    Livi, Lorenzo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Cardioprotective effect of saffron total glycoside tablets in patients with breast cancer receiving anthracycline-based chemotherapy: study protocol for a multicentre, randomised, parallel, double-blind, placebo-controlled clinical trial
    Su, Xin
    Li, Xiang-Ying
    Zhang, Yi-Jun
    Liu, Yong-Sheng
    Yuan, Chao
    Yang, Fan
    Liu, Can
    Chen, Heng-Wen
    Xiong, Xing-Jiang
    Gao, Yong-Hong
    Xing, Yan-Wei
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (07) : 8283 - 8291
12